Akebia Therapeutics
AKBA
#9606
Rank
C$0.15 B
Marketcap
C$0.55
Share price
-8.71%
Change (1 day)
-75.33%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2026 (TTM): -C$60.54 Million

According to Akebia Therapeutics's latest financial reports the company's current earnings are C$0.19 Billion. In 2025 the company made an earning of -C$5.34 Million, an increase over its 2024 earnings that were of -C$99.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$60.54 Million1034.53%
2025 -C$5.34 Million-94.64%
2024 -C$99.54 Million33.68%
2023 -C$74.46 Million-45.12%
2022 -C$0.14 Billion-66.55%
2021 -C$0.41 Billion-26.24%
2020 -C$0.55 Billion33.94%
2019 -C$0.42 Billion66.52%
2018 -C$0.25 Billion123.53%
2017 -C$0.12 Billion-43.34%
2016 -C$0.2 Billion123.58%
2015 -C$87.07 Million63.95%
2014 -C$53.11 Million181.24%
2013 -C$18.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.84 B-43,455.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$18.13 B-29,379.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
C$15.84 B-25,695.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-C$0.22 Billion 254.59%๐Ÿ‡บ๐Ÿ‡ธ USA